PortfoliosLab logoPortfoliosLab logo
BOUT vs. EBUF
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BOUT vs. EBUF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator Emerging Markets 10 Buffer ETF - Quarterly (EBUF). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BOUT achieves a 31.88% return, which is significantly higher than EBUF's 10.32% return.


BOUT

1D
-1.91%
1M
3.56%
YTD
31.88%
6M
28.55%
1Y
34.68%
3Y*
16.89%
5Y*
8.29%
10Y*

EBUF

1D
-0.39%
1M
1.18%
YTD
10.32%
6M
11.01%
1Y
15.73%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BOUT vs. EBUF - Yearly Performance Comparison


Correlation

The correlation between BOUT and EBUF is 0.62, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.62

Correlation (All Time)
Calculated using the full available price history since Jul 1, 2024

0.58

The correlation between BOUT and EBUF has been stable across timeframes, ranging from 0.58 to 0.62 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BOUT vs. EBUF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOUT
BOUT Risk / Return Rank: 5151
Overall Rank
BOUT Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
BOUT Sortino Ratio Rank: 4545
Sortino Ratio Rank
BOUT Omega Ratio Rank: 4545
Omega Ratio Rank
BOUT Calmar Ratio Rank: 6464
Calmar Ratio Rank
BOUT Martin Ratio Rank: 5454
Martin Ratio Rank

EBUF
EBUF Risk / Return Rank: 9494
Overall Rank
EBUF Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
EBUF Sortino Ratio Rank: 9494
Sortino Ratio Rank
EBUF Omega Ratio Rank: 9595
Omega Ratio Rank
EBUF Calmar Ratio Rank: 9696
Calmar Ratio Rank
EBUF Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BOUT vs. EBUF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator Emerging Markets 10 Buffer ETF - Quarterly (EBUF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BOUTEBUFDifference
Sharpe ratioReturn per unit of total volatility

-1.16

Sortino ratioReturn per unit of downside risk

-2.36

Omega ratioGain probability vs. loss probability

1.28

1.66

-0.38

Calmar ratioReturn relative to maximum drawdown

2.96

8.67

-5.71

Martin ratioReturn relative to average drawdown

8.76

34.23

-25.47

BOUT vs. EBUF - Sharpe Ratio Comparison

The current BOUT Sharpe Ratio is 1.59, which is lower than the EBUF Sharpe Ratio of 2.75. The chart below compares the historical Sharpe Ratios of BOUT and EBUF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BOUT vs. EBUF - Drawdown Comparison

The maximum BOUT drawdown since its inception was -36.98%, which is greater than EBUF's maximum drawdown of -6.49%. Use the drawdown chart below to compare losses from any high point for BOUT and EBUF.


Loading charts...

Drawdown Indicators


BOUTEBUFDifference

Max Drawdown

Largest peak-to-trough decline

-36.98%

-6.49%

-30.49%

Max Drawdown (1Y)

Largest decline over 1 year

-11.76%

-1.82%

-9.94%

Max Drawdown (3Y)

Largest decline over 3 years

-25.31%

Max Drawdown (5Y)

Largest decline over 5 years

-28.28%

Current Drawdown

Current decline from peak

-1.91%

-0.39%

-1.52%

Average Drawdown

Average peak-to-trough decline

-12.29%

-0.49%

-11.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.97%

0.46%

+3.51%

Volatility

BOUT vs. EBUF - Volatility Comparison

Innovator IBD Breakout Opportunities ETF (BOUT) has a higher volatility of 8.27% compared to Innovator Emerging Markets 10 Buffer ETF - Quarterly (EBUF) at 1.99%. This indicates that BOUT's price experiences larger fluctuations and is considered to be riskier than EBUF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BOUTEBUFDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.27%

1.99%

+6.28%

Volatility (6M)

Calculated over the trailing 6-month period

17.22%

4.85%

+12.37%

Volatility (1Y)

Calculated over the trailing 1-year period

21.92%

5.74%

+16.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.71%

6.66%

+13.05%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.00%

6.66%

+16.34%

BOUT vs. EBUF - Expense Ratio Comparison

BOUT has a 0.80% expense ratio, which is lower than EBUF's 0.89% expense ratio.


Dividends

BOUT vs. EBUF - Dividend Comparison

BOUT's dividend yield for the trailing twelve months is around 0.26%, while EBUF has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018
BOUT
Innovator IBD Breakout Opportunities ETF
0.26%0.34%0.60%1.32%1.35%0.00%0.00%0.00%0.22%
EBUF
Innovator Emerging Markets 10 Buffer ETF - Quarterly
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


BOUT and EBUF have a correlation of 0.62, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BOUT has higher volatility (8.27%) compared to EBUF (1.99%). In terms of maximum drawdown, BOUT dropped -36.98% vs EBUF's -6.49%.

On 1-year performance, BOUT leads with 34.68% vs 15.73% for EBUF. On fees, BOUT is cheaper at 0.80% per year. On volatility, EBUF has been the lower-risk option at 1.99%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, BOUT has performed better with a 34.68% return vs 15.73%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

BOUT is cheaper with a 0.80% expense ratio, compared with 0.89% for EBUF.

BOUT has the higher dividend yield at 0.26%, compared with 0.00% for EBUF.

BOUT is categorized as Mid Cap Growth Equities, while EBUF is Defined Outcome. Their fees differ too: 0.80% for BOUT and 0.89% for EBUF.

EBUF currently has the higher Sharpe Ratio (2.75 vs 1.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BOUT and EBUF

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer